English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/66458
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Genetics of scleroderma: implications for personalized medicine?

AuthorsAssassi, S.; Radstake, T. R.; Mayes, M. D.; Martín, J.
Issue Date11-Jan-2013
PublisherBioMed Central
CitationBMC Medicine 11(1) : 9- (2013)
AbstractAbstract Significant advances have been made in understanding the genetic basis of systemic sclerosis (scleroderma) in recent years. Can these discoveries lead to individualized monitoring and treatment? Besides robustly replicated genetic susceptibility loci, several genes have been recently linked to various systemic sclerosis disease manifestations. Furthermore, inclusion of genetic studies in design and analysis of drug trials could lead to development of genetic biomarkers that predict treatment response. Future genetic studies in well-characterized systemic sclerosis cohorts paired with advanced analytic approaches can lead to development of genetic biomarkers for targeted diagnostic and therapeutic interventions in systemic sclerosis.
URIhttp://hdl.handle.net/10261/66458
Identifiershttp://dx.doi.org/10.1186/1741-7015-11-9
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
1741-7015-11-9.xml73,01 kBXMLView/Open
1741-7015-11-9.pdf320,72 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.